| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(56)92048-7 |
| P698 | PubMed publication ID | 13368466 |
| P2093 | author name string | T ASTRUP | |
| P2860 | cites work | Propagation in tissue cultures of cytopathogenic agents from patients with measles | Q34235751 |
| Studies on a proteolytic enzyme system of the blood. II. Fibrinolysokinase activators for profibrinolysin | Q35181796 | ||
| The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients | Q35276722 | ||
| Fibrinolysins of human plasma; a comparison of fibrinolytic plasma from normal subjects and from cadaver blood with plasmin prepared by activation with chloroform | Q39224982 | ||
| Formation and properties of the activator of plasminogen and of human and bovine plasmin | Q42067276 | ||
| Purification and properties of some enzymes in human seminal plasma | Q42977485 | ||
| Fibrinolysis in the animal organism | Q47801143 | ||
| Observations on fibrinolysis; spontaneous activity associated with surgical operations, trauma, & c. | Q47801404 | ||
| Activation of proplasmin by a tissue fraction. | Q47853377 | ||
| An activator of plasminogen in normal urine | Q73110001 | ||
| An activator system in blood indispensable for formation of plasmin by streptokinase | Q73110317 | ||
| A plasminogen activator in spontaneously active human blood | Q73110354 | ||
| Biochemical mechanism of the allergic reaction | Q73295741 | ||
| Relationship between human seminal fluid and the fibrinolytic system | Q73371139 | ||
| A fibrinolytic system in human milk | Q73413173 | ||
| The formation of white deposits in tissue cultures in the presence of organic phosphates | Q73437368 | ||
| Diet and coronary disease | Q73467281 | ||
| Mural thrombosis in arteries | Q73713809 | ||
| Fibrinolytic activity in the circulating blood following amniotic fluid infusion | Q73923902 | ||
| A fibrinolytic system in human amniotic fluid | Q73923919 | ||
| The plasminogen activator in urine and the urinary trypsin inhibitor | Q73942672 | ||
| Fibrinolytic activity in human saliva | Q73953223 | ||
| The incorporation of fibrin in the aortic intima | Q73963890 | ||
| The plasminogen activator in animal tissue | Q74001378 | ||
| The fibrinolytic activity of menstrual blood | Q74279445 | ||
| Fibrinolytic activity in human tears | Q78746370 | ||
| Use of antitryptic agents in tissue culture; crude soybean trypsin-inhibitor | Q80365460 | ||
| Pathogenesis of atherosclerosis | Q80624819 | ||
| The Application of Soybean Inhibitor in Tissue Cultivation | Q81128936 | ||
| P433 | issue | 6942 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 565-568 | |
| P577 | publication date | 1956-09-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | The biological significance of fibrinolysis | |
| P478 | volume | 271 |
| Q35461086 | ARTERIOSCLEROSIS IN MAN, OTHER MAMMALS AND BIRDS |
| Q42538550 | Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis |
| Q54354531 | Alterations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic-receptor stimulation. |
| Q78847566 | Antifibrinolytic activity and metabolism of 6-aminocaproic acid in man |
| Q74691416 | Atherosclerosis in a haemophiliac |
| Q84946132 | Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease |
| Q45229277 | Blood coagulation, fibrinolysis and coronary heart disease: observations in Malaysia |
| Q78872814 | Blood lipids, mucoproteins, and fibrinolytic activity in diabetic Indians and Africans in Natal. Possible relation to vascular complications |
| Q34302590 | Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications. |
| Q50284514 | CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA. |
| Q69872016 | Chronic interstitial cystitis and subcutaneous heparin |
| Q37054785 | Circadian Variation of Fibrinolytic Activity in Blood |
| Q73502266 | Coagulation activation in patients undergoing directional coronary atherectomy |
| Q48819751 | Combined immunodeficiency and chronic encephalitis |
| Q24569578 | Coronary heart disease and physical activity of work; evidence of a national necropsy survey |
| Q84946177 | Defibrination Syndrome |
| Q72594376 | Diagnosis of deep-vein thrombosis |
| Q35228199 | Dowling oration 1975. Fibrinolysis and vasculitis |
| Q68818773 | Editorial: Fibrinolysis and venous thrombosis |
| Q52129535 | Effect of mental stress on the fibrinolytic reactivity to exercise |
| Q64967441 | Effect of moderate exercise on the fibrinolytic system in normal young men and women |
| Q36792269 | Effect of submaximal exercise on fibrinolytic activity in ischaemic heart disease |
| Q59009144 | Effects of Fibrin Surface on Coagulation of Blood |
| Q93701524 | Endothelial fibrinolysis and blood flow |
| Q53747300 | Ethyloestrenol and postoperative venous thrombosis. |
| Q39876412 | Evaluation of drug therapy in chronic diseases |
| Q78801849 | Evidence for the adsorption upon erythrocytes of urokinase and other components of the fibrinolytic system |
| Q45867616 | FIBRINOLYTIC SYSTEM IN CERTAIN CONGENITAL AND HEREDITARY HAEMORRHAGIC DISORDERS: A CRITICAL EVALUATION OF THE THEORY OF DYNAMIC HAEMOSTASIS. |
| Q71530194 | Fibrin Degradation Products in Pre-eclamptic Toxaemia and Eclampsia |
| Q41030793 | Fibrin and atherogenesis — A hypothesis |
| Q72315663 | Fibrin degradation products in sera of normal subjects |
| Q36062704 | Fibrin-fibrinogen degradation products in sera of normal infants and children |
| Q39461091 | Fibrinogen and fibrin: biochemistry and pathophysiology |
| Q39770207 | Fibrinogen subunit degradation in vitro: Studies on human fibrinogen heterogeneity |
| Q72111679 | Fibrinolysis and body bulid. Interrelationships between blood fibrinolysis, body composition and parameters of lipid and carbohydrate metabolism |
| Q70059653 | Fibrinolysis and plasminogen levels in pregnancy and the puerperium |
| Q35004542 | Fibrinolysis in colonic disease |
| Q38897683 | Fibrinolysis in relation to body fatness, serum lipids and coronary heart disease in African and Asian men in Uganda |
| Q71119909 | Fibrinolytic Activity in the Normal and Inflamed Rectal Mucosa |
| Q58955174 | Fibrinolytic Activity of Cirrhotic Liver |
| Q59031944 | Fibrinolytic Response to Moderate, Exhaustive and Prolonged Exercise in Normal Subjects |
| Q72252351 | Fibrinolytic activity in the clinical crisis of sickle-cell anaemia |
| Q70400267 | Fibrinolytic activity in the closed ductus arteriosus |
| Q47964359 | Fibrinolytic activity of human brain. A histochemical study |
| Q78846193 | Fibrinolytic activity of the blood in intermittent claudication |
| Q34696935 | Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo |
| Q50328343 | Fibrinolytic response to moderate exercise in 50 healthy middle-aged subjects |
| Q41223423 | Fibrinolytic response to moderate exercise in young male diabetics and non-diabetics |
| Q40642742 | Formation and fate of fibrin clots in the biliary tract: a clinical and experimental study |
| Q77108485 | HAEMORRHAGIC DIATHESIS DUE TO ABRUPTIO PLACENTAE TREATED BY FIBRINOGEN, EPSILON-AMINOCAPROIC ACID, AND HYSTEROTOMY |
| Q47840204 | Haemostatic mechanisms in the animal arterial wall |
| Q41291922 | Hepatic and cardiac necrosis in a patient with prostatic carcinoma given 6-aminocaproic acid |
| Q85571617 | Histochemical studies on the onset of chronic lesions |
| Q41141603 | Hormone replacement therapy and hemostasis: principles of a complex interaction |
| Q78306325 | IN VIVO ACTIVATION OF THE FIBRINOLYTIC SYSTEM OF THE CAT. EFFECT OF STREPTOKINASE, TRYPSIN AND GLYCEROL |
| Q55716840 | IS ATHEROSCLEROSIS REVERSIBLE? |
| Q67448435 | In Vivo Behaviour of Homologous Urea‐Soluble 131I‐Fibrin and 125I‐Fibrinogen in Rabbits: the Effect of Fibrinolysis Inhibition |
| Q78841977 | Intravenous Administration of Fibrinolysin: Its Systemic Toxicity and Effect Upon Components of the Coagulation Mechanism |
| Q67348792 | Investigations on Antithrombin III in Normal Plasma and Serum |
| Q37149080 | Iron-induced fibrin in cardiovascular disease |
| Q41446397 | Lack of effect of an antifibrinolytic agent on cholesterol-induced aortic lesions in the rat, with observations on the independence of intimal foam cell lesions and extracellular medial lipid |
| Q37091275 | Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. |
| Q47715508 | Measuring fibrinolysis: from research to routine diagnostic assays |
| Q74531270 | Mechanical factors in atherosclerosis |
| Q41722143 | Minor Hemobilia Clinical Significance and Pathophysiological Background |
| Q67314560 | Natural fibrinolysis |
| Q54017038 | Non-medical administrators in the medical alliance. |
| Q34086042 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms |
| Q78896429 | On thrombolysis studies on the rabbit with combined nicotinic acid-heparin therapy |
| Q77153924 | PHENFORMIN IN RHEUMATOID ARTHRITIS. A FIBRINOLYTIC APPROACH |
| Q34310277 | Pathophysiology of oxidative stress in diabetes mellitus |
| Q39401678 | Physiology and pathophysiology of the plasminogen system in the kidney |
| Q36805927 | Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in acute myocardial infarction |
| Q37057851 | Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in young patients with ischaemic stroke |
| Q35742862 | Platelets, thrombosis and vascular disease. |
| Q67438926 | Presence of fibrin prolongs the retainment of locally injected tissue plasminogen activator |
| Q54750401 | Previously undescribed fibrinolysis inhibitor in human blood. |
| Q69178636 | Primary Pulmonary Aspergillosis with High Fibrinolytic Activity in the Aortic Intima |
| Q52696605 | Purification and characterization of fibrinolytic enzyme from a bacterium isolated from soil. |
| Q72107926 | Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin |
| Q79615817 | Relationship between blood fibrinoytic activity and body fatness |
| Q70477712 | Repair in arterial tissue. Demonstration of fibrinogen/fibrin in the normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique |
| Q67313746 | Response of fibrinolytic activity to venous occlusion |
| Q70098481 | Serum fibrin degradation products throughout normal pregnancy |
| Q36705299 | Significance of idiopathic deep venous thrombosis |
| Q78529190 | Some factors determining thrombus formation in acute coronary thrombosis |
| Q64913297 | Standardization of Measurement of Components of the Fibrinolytic System - Introduction and Current Status. |
| Q41364942 | Studies in blood coagulation, diet, and ischaemic heart disease in two population groups in India |
| Q44729840 | Studies of leukocytic fibrinolysis |
| Q93808996 | Studies on Pharmacological Enhancement of Blood Fibrinolytic Activity |
| Q34099701 | Studies on enhanced fibrinolytic activity in man. |
| Q74613968 | Studies on the inhibition of fibrinolysis by lipids |
| Q35564843 | Studies on the thrombolytic activity of human plasma |
| Q36542802 | Surface lining cells of healing thrombi in rat femoral veins: An electron-microscope study |
| Q93804114 | The Coagulation Mechanism in Acute Bacterial Infection |
| Q72220682 | The Fibrinolytic Response to Moderate Exercise and Intravenous Adrenaline in the Same Subjects |
| Q39921140 | The Role of Platelets in Arterial and Venous Thrombosis |
| Q42071745 | The activation of plasminogen by staphylokinase: comparison with streptokinase |
| Q72242559 | The effect of fat feeding on fibrinolysis, “Stypven” time and platelet aggregation |
| Q78864232 | The effect of long term feeding of essential fatty acids on blood coagulation and fibrinolysis |
| Q70494692 | The effect of surgical preparation and in-vitro distension on the intrinsic fibrinolytic activity of human saphenous vein |
| Q36258741 | The growth and death of wound bacteria in serum, exudate and slough |
| Q41012475 | The identification and localization of antithrombin III in human tissues |
| Q35532826 | The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: A review of 639 cases of cirrhosis of the liver from 17,731 autopsies |
| Q35898887 | The role of the fibrinolytic system in thromboembolism |
| Q40831957 | The thrombogenic hypothesis and its implications |
| Q47986653 | The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage |
| Q59384963 | Timecourse of fibrin deposition and removal after arterial injury |
| Q40176121 | Toxicological assessment of the hemostatic system, regulatory requirements, and industry practice |
| Q79595830 | Turnover of 131-I fibrinogen in coronary heart disease and lipemia |
| Q33189461 | Unexpected post-operative bleeding due to haemorrhagic disease |
| Q79312498 | Use of anticoagulant and fibrinolytic agents |
| Q69530735 | [Comparative thrombelastographic study on citrated sternal marrow blood and venous blood] |
| Q78389111 | [Effect of dietary fats on blood coagulation and its possible significance in arteriosclerosis] |
Search more.